Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Taiwan University Hospital
Beijing Tiantan Hospital
Nationwide Children's Hospital
Case Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Tianjin Medical University Cancer Institute and Hospital
Mayo Clinic
Tianjin Medical University Cancer Institute and Hospital
Bristol-Myers Squibb
Vanderbilt-Ingram Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
The University of Texas Health Science Center at San Antonio
Washington University School of Medicine
Washington University School of Medicine
Yale University
Baptist Health South Florida
Maastricht University Medical Center
GCS Ramsay Santé pour l'Enseignement et la Recherche
Vanderbilt-Ingram Cancer Center
The Cooper Health System
Exelixis
Duke University
King's College Hospital NHS Trust
University of California, San Francisco
Insel Gruppe AG, University Hospital Bern
OHSU Knight Cancer Institute
University of Malaya
Dana-Farber Cancer Institute
Hospital del Rio Hortega
Tianjin Medical University Cancer Institute and Hospital
University of Pittsburgh
Zhejiang Cancer Hospital
Medical College of Wisconsin
Prof. Franciszek Lukaszczyk Memorial Oncology Center
Medical College of Wisconsin
University of Cincinnati
Nanfang Hospital, Southern Medical University
Tanta University
Beta Emitting Accurate Monitored Systems
VPIX Medical
University of California, San Francisco
Medical College of Wisconsin
Sun Yat-sen University
Aalborg University Hospital
Peking University Cancer Hospital & Institute
University Hospital, Toulouse
Centre Paul Strauss
Case Comprehensive Cancer Center